Barclays’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $753K | Sell |
46,376
-65,243
| -58% | -$1.15M | ﹤0.01% | 2930 |
|
|
2025
Q4 | $2.09M | Sell |
111,619
-3,772
| -3% | -$62.6K | ﹤0.01% | 2904 |
|
|
2025
Q3 | $1.68M | Sell |
115,391
-16,411
| -12% | -$207K | ﹤0.01% | 3003 |
|
|
2025
Q2 | $1.45M | Buy |
131,802
+79,769
| +153% | +$776K | ﹤0.01% | 3087 |
|
|
2025
Q1 | $465K | Sell |
52,033
-22,757
| -30% | -$212K | ﹤0.01% | 3571 |
|
|
2024
Q4 | $704K | Buy |
74,790
+9,210
| +14% | +$83.8K | ﹤0.01% | 3616 |
|
|
2024
Q3 | $529K | Buy |
65,580
+48,316
| +280% | +$419K | ﹤0.01% | 3742 |
|
|
2024
Q2 | $146K | Sell |
17,264
-27,747
| -62% | -$250K | ﹤0.01% | 3734 |
|
|
2024
Q1 | $404K | Sell |
45,011
-37,346
| -45% | -$346K | ﹤0.01% | 3721 |
|
|
2023
Q4 | $926K | Buy |
82,357
+59,088
| +254% | +$595K | ﹤0.01% | 3490 |
|
|
2023
Q3 | $201K | Sell |
23,269
-5,554
| -19% | -$53.6K | ﹤0.01% | 3296 |
|
|
2023
Q2 | $298K | Sell |
28,823
-7,779
| -21% | -$85.9K | ﹤0.01% | 3047 |
|
|
2023
Q1 | $397K | Buy |
36,602
+12,979
| +55% | +$137K | ﹤0.01% | 3422 |
|
|
2022
Q4 | $265K | Buy |
23,623
+12,425
| +111% | +$131K | ﹤0.01% | 3695 |
|
|
2022
Q3 | $114K | Sell |
11,198
-9,769
| -47% | -$91.5K | ﹤0.01% | 3490 |
|
|
2022
Q2 | $190K | Sell |
20,967
-7,657
| -27% | -$70.6K | ﹤0.01% | 3456 |
|
|
2022
Q1 | $274K | Sell |
28,624
-65,785
| -70% | -$645K | ﹤0.01% | 3246 |
|
|
2021
Q4 | $1.04M | Buy |
94,409
+35,619
| +61% | +$310K | ﹤0.01% | 2808 |
|
|
2021
Q3 | $435K | Buy |
58,790
+51,922
| +756% | +$581K | ﹤0.01% | 3255 |
|
|
2021
Q2 | $100K | Sell |
6,868
-44,452
| -87% | -$835K | ﹤0.01% | 3844 |
|
|
2021
Q1 | $1.05M | Buy |
51,320
+25,216
| +97% | +$479K | ﹤0.01% | 2747 |
|
|
2020
Q4 | $464K | Sell |
26,104
-17,016
| -39% | -$305K | ﹤0.01% | 3283 |
|
|
2020
Q3 | $637K | Sell |
43,120
-28,124
| -39% | -$527K | ﹤0.01% | 3043 |
|
|
2020
Q2 | $1.5M | Buy |
71,244
+27,721
| +64% | +$712K | ﹤0.01% | 2391 |
|
|
2020
Q1 | $1M | Sell |
43,523
-11,185
| -20% | -$280K | ﹤0.01% | 2943 |
|
|
2019
Q4 | $1.42M | Buy |
54,708
+9,628
| +21% | +$187K | ﹤0.01% | 3343 |
|
|
2019
Q3 | $879K | Sell |
45,080
-65,159
| -59% | -$1.32M | ﹤0.01% | 3780 |
|
|
2019
Q2 | $1.8M | Buy |
110,239
+66,146
| +150% | +$1.34M | ﹤0.01% | 3047 |
|
|
2019
Q1 | $1M | Buy |
44,093
+25,341
| +135% | +$643K | ﹤0.01% | 3404 |
|
|
2018
Q4 | $481K | Sell |
18,752
-12,734
| -40% | -$344K | ﹤0.01% | 3854 |
|
|
2018
Q3 | $1.03M | Buy |
31,486
+28,347
| +903% | +$773K | ﹤0.01% | 3588 |
|
|
2018
Q2 | $72K | Sell |
3,139
-8,686
| -73% | -$206K | ﹤0.01% | 5441 |
|
|
2018
Q1 | $286K | Buy |
11,825
+2,933
| +33% | +$80.6K | ﹤0.01% | 4499 |
|
|
2017
Q4 | $248K | Buy |
8,892
+6,562
| +282% | +$194K | ﹤0.01% | 4504 |
|
|
2017
Q3 | $79K | Buy |
2,330
+563
| +32% | +$18.4K | ﹤0.01% | 5093 |
|
|
2017
Q2 | $71K | Sell |
1,767
-14,708
| -89% | -$565K | ﹤0.01% | 5138 |
|
|
2017
Q1 | $607K | Buy |
16,475
+12,857
| +355% | +$411K | ﹤0.01% | 3217 |
|
|
2016
Q4 | $115K | Buy |
3,618
+1,692
| +88% | +$52.5K | ﹤0.01% | 4648 |
|
|
2016
Q3 | $71K | Sell |
1,926
-11,563
| -86% | -$322K | ﹤0.01% | 4758 |
|
|
2016
Q2 | $305K | Buy |
13,489
+13,106
| +3,422% | +$283K | ﹤0.01% | 3612 |
|
|
2016
Q1 | $7K | Sell |
383
-6,667
| -95% | -$109K | ﹤0.01% | 5585 |
|
|
2015
Q4 | $113K | Sell |
7,050
-2,007
| -22% | -$31.9K | ﹤0.01% | 4330 |
|
|
2015
Q3 | $90K | Buy |
9,057
+8,486
| +1,486% | +$108K | ﹤0.01% | 4686 |
|
|
2015
Q2 | $7K | Sell |
571
-567
| -50% | -$8.79K | ﹤0.01% | 6289 |
|
|
2015
Q1 | $19K | Sell |
1,138
-3,018
| -73% | -$55.3K | ﹤0.01% | 5866 |
|
|
2014
Q4 | $59K | Buy |
4,156
+724
| +21% | +$12.6K | ﹤0.01% | 5593 |
|
|
2014
Q3 | $80K | Sell |
3,432
-3,641
| -51% | -$106K | ﹤0.01% | 5505 |
|
|
2014
Q2 | $220K | Buy |
+7,073
| New | +$213K | ﹤0.01% | 4729 |
|
Other funds holding TBPH
MAP
WAM
NM
ICM
VCM
